Gardiner Healthcare Acquisitions Corp. Unit
GDNRU
GDNRU was delisted on the 15th of November, 2023.
8 hedge funds and large institutions have $6.27M invested in Gardiner Healthcare Acquisitions Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
9% less capital invested
Capital invested by funds: $6.89M → $6.27M (-$618K)
11% less funds holding
Funds holding: 9 → 8 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$6.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$568K |
GDNRU Hedge Fund Activity: Q3 2022 in Review
8 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) for Q3 2022, worth a combined $6.27M — down 9% from $6.89M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GDNRU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $6.22K. The largest seller was Mangrove Partners, exiting entirely with an estimated $568K sold.
- 8 institutional investors held Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) as of Q3 2022, down from 9 in Q2 2022.
- Funds reported $6.27M of Gardiner Healthcare Acquisitions Corp. Unit stock for Q3 2022, down 9% quarter-over-quarter.
- 0 funds opened new Gardiner Healthcare Acquisitions Corp. Unit positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Gardiner Healthcare Acquisitions Corp. Unit buyer in Q3 2022 was Clear Street, an estimated $6.22K added.
- The largest Gardiner Healthcare Acquisitions Corp. Unit seller in Q3 2022 was Mangrove Partners, an estimated $568K sold.
Based on aggregated 13F filings for Q3 2022.